Sonoma Pharmaceuticals, Inc. — Director's Dealing 2014

Dec 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2014-12-01

Reporting Person: MCLAUGHLIN JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-01	Stock Options (right to buy)	$1.40	A	6773	Acquired	2024-12-01	Common Stock (6773)	Direct

Footnotes

F1: The options vest immediately, on the date such options were granted.

F2: The option was granted by the Issuer pursuant to the Non-Employee Director Compensation Plan.